Search research articles
Contact Us
Filters
Showing results (111-120 of 171) with videos related to
Page
of 18
Sort By:
The American Journal of Managed Care
|
November 20, 2018
Venous thromboembolism in acute medically ill patients: identifying unmet needs and weighing the value of prophylaxis
Paul P Dobesh, Tania Ahuja, George A Davis, et al.
Circulation
|
March 30, 2005
Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model
Yan Li, Tetsuo Minamino, Osamu Tsukamoto, et al.
Cell Research
|
February 8, 2012
Defining the expressed breast cancer kinome
Alicia A Midland, Martin C Whittle, James S Duncan, et al.
The American Journal of Managed Care
|
November 20, 2018
Best practices for implementing venous thromboembolism prophylaxis across the continuum of care
Paul P Dobesh, Tania Ahuja, George A Davis, et al.
Peerj
|
September 2, 2024
Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines
Matthew E Berginski, Madison R Jenner, Chinmaya U Joisa, et al.
Cancer Research
|
November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging
Hailey E Brighton, Steven P Angus, Tao Bo, et al.
Cancer Cell International
|
April 5, 2016
Weight loss reduces basal-like breast cancer through kinome reprogramming
Yuanyuan Qin, Sneha Sundaram, Luma Essaid, et al.
Cell Stem Cell
|
May 10, 2011
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells
Amy N Abell, Nicole Vincent Jordan, Weichun Huang, et al.
Journal of the American Heart Association
|
October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
Timothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Molecular Cancer Research : MCR
|
August 6, 2020
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Daniel R Goulet, Joseph P Foster, Jon S Zawistowski, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 171) with videos related to
Sort By:
Page
of 18
The American Journal of Managed Care
|
November 20, 2018
Venous thromboembolism in acute medically ill patients: identifying unmet needs and weighing the value of prophylaxis
Paul P Dobesh, Tania Ahuja, George A Davis, et al.
Circulation
|
March 30, 2005
Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model
Yan Li, Tetsuo Minamino, Osamu Tsukamoto, et al.
Cell Research
|
February 8, 2012
Defining the expressed breast cancer kinome
Alicia A Midland, Martin C Whittle, James S Duncan, et al.
The American Journal of Managed Care
|
November 20, 2018
Best practices for implementing venous thromboembolism prophylaxis across the continuum of care
Paul P Dobesh, Tania Ahuja, George A Davis, et al.
Peerj
|
September 2, 2024
Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines
Matthew E Berginski, Madison R Jenner, Chinmaya U Joisa, et al.
Cancer Research
|
November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging
Hailey E Brighton, Steven P Angus, Tao Bo, et al.
Cancer Cell International
|
April 5, 2016
Weight loss reduces basal-like breast cancer through kinome reprogramming
Yuanyuan Qin, Sneha Sundaram, Luma Essaid, et al.
Cell Stem Cell
|
May 10, 2011
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells
Amy N Abell, Nicole Vincent Jordan, Weichun Huang, et al.
Journal of the American Heart Association
|
October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
Timothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Molecular Cancer Research : MCR
|
August 6, 2020
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Daniel R Goulet, Joseph P Foster, Jon S Zawistowski, et al.
Page
of 18